Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RIBOGENE: Optimisation of Riboflavin Status in Hypertensive Adults With a Genetic Predisposition to Elevated Blood Pressure

NCT02463513 is registered in ClinicalTrials.gov with University of Ulster as lead sponsor.

NCT NCT02463513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02463513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RIBOGENE: Optimisation of Riboflavin Status in Hypertensive Adults With a Genetic Predisposition to Elevated Blood Pressure
Lead sponsor
University of Ulster
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2013
Completion date
December 31, 2017
Enrollment
243 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

participants with the mthfr 677tt genotype